Literature DB >> 13943717

The electrophoresis of human gastric juice. I. In normal controls.

D W PIPER, M C STIEL, J E BUILDER.   

Abstract

The electrophoretic pattern of normal human gastric juice is described. The effect of autodigestion of gastric juice and of the peptic digestion of albumin is described. The fallacies involved in the study of gastric juice proteins where peptic digestion of the protein constituent has not been prevented are emphasized. In this study the gastric juice was neutralized within the stomach to prevent changes due to autodigestion.

Entities:  

Keywords:  ANEMIA, PERNICIOUS; ELECTROPHORESIS; GASTRIC JUICE; STOMACH ULCER

Mesh:

Year:  1962        PMID: 13943717      PMCID: PMC1413391          DOI: 10.1136/gut.3.4.349

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Passage of serum albumin into the stomach. Its detection by paper electrophoresis of gastric juice in protein-losing gastropathies and gastric cancer.

Authors:  G B GLASS; A ISHIMORI
Journal:  Am J Dig Dis       Date:  1961-02

2.  Comparative studies of the protein fractions from human gastrointestinal juices with paper electrophoresis combined with various detection methods.

Authors:  J C VERSCHURE
Journal:  Clin Chim Acta       Date:  1959-01       Impact factor: 3.786

3.  Isolation and crystallization of gastricsin from human gastric juice.

Authors:  J TANG; S WOLF; R CAPUTTO; R E TRUCCO
Journal:  J Biol Chem       Date:  1959-05       Impact factor: 5.157

4.  Gastrointestinal protein loss in idiopathic (hypercatabolic) hypoproteinaemia.

Authors:  M SCHWARTZ; S JARNUM
Journal:  Lancet       Date:  1959-02-14       Impact factor: 79.321

5.  Exudative enteropathy: abnormal permeability of the gastrointestinal tract demonstrable with labelled polyvinylpyrrolidone.

Authors:  R S GORDON
Journal:  Lancet       Date:  1959-02-14       Impact factor: 79.321

6.  The mechanism of hypoproteinemia associated with giant hypertrophy of the gastric mucosa.

Authors:  Y CITRIN; K STERLING; J A HALSTED
Journal:  N Engl J Med       Date:  1957-11-07       Impact factor: 91.245

7.  Idiopathic of hypercatabolic hypoproteinaemia; case examined by 131I-labelled albumin.

Authors:  M SCHWARTZ; B THOMSEN
Journal:  Br Med J       Date:  1957-01-05

8.  Paper-electrophoretic analysis of gastric juice in health and disease and its physiological and clinical significance.

Authors:  G B J GLASS; M RICH; L STEPHANSON
Journal:  Gastroenterologia       Date:  1956

9.  [Electrophoretic description of proteins in the normal and pathological gastric juice].

Authors:  N HENNING; H KINZLMEIER; L DEMLING
Journal:  Munch Med Wochenschr       Date:  1953-04-10

10.  Proteins of canine gastric juice; electrophoretic characterization and separation and fractions.

Authors:  A L GROSSBERG; S A KOMAROV; H SHAY
Journal:  Am J Physiol       Date:  1951-04-01
View more
  6 in total

1.  A MUCUS-SECRETING VILLOUS ADENOMA OF THE RECTUM.

Authors:  P B ROWE
Journal:  Gut       Date:  1964-06       Impact factor: 23.059

2.  NONDIALYZABLE B12 BINDING MATERIAL IN HUMAN GASTRIC JUICE FOLLOWING HISTAMINE STIMULATION.

Authors:  J D WELSH; J T HARTZOG; J C MAY; L RUSSELL
Journal:  Am J Dig Dis       Date:  1964-04

3.  Protein content of gastric juice: Part II In normal subjects and patients suffering from peptic ulcer and gastric carcinoma.

Authors: 
Journal:  Gut       Date:  1965-12       Impact factor: 23.059

4.  Protein content of gastric juice.

Authors:  D W Piper; E M Griffith; B H Fenton; D Beeston
Journal:  Gut       Date:  1965-12       Impact factor: 23.059

5.  Effects of in-vitro neutralization on the composition of the nondialyzable components of human gastric juice.

Authors:  J D Welsh; C D Wallace; A Walker; L Russell
Journal:  Am J Dig Dis       Date:  1967-04

6.  THE ELECTROPHORETIC PATTERN OF NORMAL HUMAN GASTRIC JUICE AND OF THE GASTRIC JUICE OF PATIENTS WITH GASTRIC ULCER AND GASTRIC CANCER.

Authors:  D W PIPER; M C STIEL; J E BUILDER
Journal:  Gut       Date:  1963-09       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.